MX2015006376A - Casete de expresion optimizado para expresar un polipeptido con un alto rendimiento. - Google Patents

Casete de expresion optimizado para expresar un polipeptido con un alto rendimiento.

Info

Publication number
MX2015006376A
MX2015006376A MX2015006376A MX2015006376A MX2015006376A MX 2015006376 A MX2015006376 A MX 2015006376A MX 2015006376 A MX2015006376 A MX 2015006376A MX 2015006376 A MX2015006376 A MX 2015006376A MX 2015006376 A MX2015006376 A MX 2015006376A
Authority
MX
Mexico
Prior art keywords
polypeptide
expressing
high yield
expression cassette
interest
Prior art date
Application number
MX2015006376A
Other languages
English (en)
Other versions
MX359950B (es
Inventor
Zorica Dragic
Rita Schmitz
Burkhard Wilms
Sabine Geisse
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2015006376A publication Critical patent/MX2015006376A/es
Publication of MX359950B publication Critical patent/MX359950B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/30Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se basa en el descubrimiento de que la combinación de una secuencia de polinucleótidos de 5'UTR específica (ver SEQ ID NO 1) y la secuencia líder secretora de hCD33 en un casete de expresión para expresar un polinucleótido de interés da como resultado un nivel de expresión sorprendentemente mejor del polipéptido de interés comparándose con los casetes de expresión de la técnica anterior. Basándose en este descubrimiento, la presente invención, entre otras cosas, proporciona novedosos casetes de expresión, vectores de expresión y métodos para producir un polipéptido de interés con un alto rendimiento.
MX2015006376A 2012-11-20 2013-11-18 Casete de expresión optimizado para expresar un polipéptido con un alto rendimiento. MX359950B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261728459P 2012-11-20 2012-11-20
PCT/EP2013/074114 WO2014079819A1 (en) 2012-11-20 2013-11-18 Optimized expression cassette for expressing a polypeptide with high yield

Publications (2)

Publication Number Publication Date
MX2015006376A true MX2015006376A (es) 2015-10-05
MX359950B MX359950B (es) 2018-10-17

Family

ID=49585414

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015006376A MX359950B (es) 2012-11-20 2013-11-18 Casete de expresión optimizado para expresar un polipéptido con un alto rendimiento.

Country Status (18)

Country Link
US (2) US9663797B2 (es)
EP (1) EP2922962B1 (es)
JP (1) JP6388592B2 (es)
KR (1) KR102286389B1 (es)
CN (2) CN113981002A (es)
AU (1) AU2013349844B2 (es)
BR (1) BR112015011061B1 (es)
CA (1) CA2891388C (es)
DK (1) DK2922962T3 (es)
ES (1) ES2620325T3 (es)
IL (1) IL238703B (es)
LT (1) LT2922962T (es)
MX (1) MX359950B (es)
PL (1) PL2922962T3 (es)
PT (1) PT2922962T (es)
RU (1) RU2682884C2 (es)
SG (1) SG11201503326PA (es)
WO (1) WO2014079819A1 (es)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431140A1 (de) 1984-08-24 1986-03-06 Behringwerke Ag, 3550 Marburg Enhancer fuer eukaryotische expressionssysteme
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
ATE452207T1 (de) 1992-08-21 2010-01-15 Univ Bruxelles Immunoglobuline ohne leichte ketten
EP1716233B1 (en) 2004-01-30 2009-08-26 Maxygen Holdings Ltd. Regulated stop codon readthrough
JP4722048B2 (ja) 2004-07-27 2011-07-13 独立行政法人理化学研究所 N−デアセチラーゼ/n−スルホトランスフェラーゼ2を発現するベクター
WO2007131774A1 (en) 2006-05-17 2007-11-22 F. Hoffmann-La Roche Ag Polypeptide producing cells
SG176501A1 (en) * 2006-08-23 2011-12-29 Selexis Sa Matrix attachment regions (mars) for increasing transcription and uses thereof
CN101679497A (zh) 2007-03-26 2010-03-24 津莫吉尼蒂克斯公司 可溶性il-17ra/rc融合蛋白以及相关方法
JP5701061B2 (ja) * 2007-12-21 2015-04-15 ノバルティス アーゲー 哺乳類発現ベクター
EP2227549B1 (en) 2007-12-21 2015-06-17 Novartis AG Selection system for eukaryotic cell culture based on a membrane-bound folate receptor gene
CA2726862A1 (en) * 2008-06-30 2010-01-21 Atgcell Inc. Mammalian cell expression vectors and utilization
ES2413379T3 (es) 2008-08-28 2013-07-16 Novartis Ag Presentación en la superficie celular de isoformas polipeptídicas mediante ultralectura de codón de terminación
BRPI1009752B1 (pt) 2009-02-27 2020-03-10 Novartis Ag Vetor de expressão ou uma combinação de pelo menos dois vetores de expressão e métodos para sua produção e sua seleção, bem como processo para produzir um produto de interesse e uso de um meio de cultura seletivo

Also Published As

Publication number Publication date
BR112015011061A2 (pt) 2017-08-22
US20170356006A1 (en) 2017-12-14
PT2922962T (pt) 2017-03-29
RU2015124041A (ru) 2017-01-10
CN104968791B (zh) 2021-11-19
LT2922962T (lt) 2017-04-10
MX359950B (es) 2018-10-17
RU2682884C2 (ru) 2019-03-22
US9663797B2 (en) 2017-05-30
EP2922962B1 (en) 2016-12-21
CN113981002A (zh) 2022-01-28
AU2013349844B2 (en) 2017-03-02
US11230718B2 (en) 2022-01-25
AU2013349844A1 (en) 2015-05-21
CA2891388C (en) 2021-09-14
IL238703A0 (en) 2015-06-30
PL2922962T3 (pl) 2017-06-30
ES2620325T3 (es) 2017-06-28
JP6388592B2 (ja) 2018-09-12
US20160186206A1 (en) 2016-06-30
KR20150085537A (ko) 2015-07-23
EP2922962A1 (en) 2015-09-30
SG11201503326PA (en) 2015-06-29
CA2891388A1 (en) 2014-05-30
KR102286389B1 (ko) 2021-08-05
WO2014079819A1 (en) 2014-05-30
IL238703B (en) 2019-02-28
JP2015535427A (ja) 2015-12-14
BR112015011061A8 (pt) 2020-03-17
CN104968791A (zh) 2015-10-07
DK2922962T3 (en) 2017-03-27
BR112015011061B1 (pt) 2022-09-27

Similar Documents

Publication Publication Date Title
PH12018501628A1 (en) Optimized factor viii genes
GEP20166429B (es)
EP3741849A3 (en) Protease variants and polynucleotides encoding same
MX2019011040A (es) Composiciones y metodos para potenciar la expresion genica.
EA201690529A1 (ru) Способы модификации клетки-хозяина
RU2014148136A (ru) Композиции т-клеток с недостаточностью рецепторов т-клеток
EA201590488A1 (ru) Способы модификации клеток-хозяев
IN2014CN04586A (es)
IN2015DN02771A (es)
MX2017000181A (es) Celulas madre limbales de mamifero cultivadas, metodos para generarlas y sus usos.
IN2014CN02469A (es)
MX355356B (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
MX2014004539A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
MX2022001085A (es) Anticuerpos anti-c1s humanizados y metodos para usarlos.
MX2020003508A (es) Un factor de secrecion de proteinas con alta eficacia secretora y un vector de expresion que lo comprende.
MX2018014043A (es) Composiciones de cultivo celular con antioxidantes y metodos para la produccion de polipeptidos.
NZ756132A (en) Method for producing multispecific antibodies
MX2016011465A (es) Drimenol-sintasas y metodos para producir drimenol.
IN2014DN10111A (es)
MX358243B (es) Anticuerpos anti-vasa y metodos de produccion y uso de los mismos.
PH12016502024B1 (en) Tonoplast proton/sugar antiporter proteins and the use thereof to increase the saccharose concentration in a saccharose storage organ of plants
MX2014007446A (es) Variantes de subtilasa y polinucleotidos que las codifican.
MX2017005295A (es) Marcador de seleccion novedoso para transfeccion celular y produccion de proteinas.
MX2016013955A (es) Drimenol-sintasas y metodo de produccion de drimenol.
NZ702345A (en) Lentiviral vectors containing an mhc class i promoter

Legal Events

Date Code Title Description
FG Grant or registration